基于(关键地区、市场参与者、规模和份额)的通用注射剂市场 - 到 2031 年的预测

  • Report Code : TIPRE00004765
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 217
Buy Now

仿制药注射剂市场预计将从 2021 年的 747.4 亿美元增至 2028 年的 1506.5 亿美元;预计 2021 年至 2028 年复合年增长率为 10.5%。

仿制药注射剂是品牌注射剂的生物等效物,不受专利保护。它们作为创新药是安全有效的,因为它们具有相似的活性成分、剂量、强度、质量、形式等。

该报告提供了对仿制药注射剂市场的见解和深入分析,强调各种参数,例如市场趋势、技术进步和市场动态;它还提供了主要市场参与者的竞争格局分析以及 COVID-19 大流行对所有主要地区市场的影响。 COVID-19 大流行扰乱了世界各国的社会经济状况。根据世界卫生组织最新统计,美国是全球疫情最严重、病例数最多的国家。大量新冠病例对美国经济以及北美经济产生了负面影响。该地区的整体商业活动有所下降,各行业的增长也有所增长。

战略见解

但是,对瑞德西韦(Remdesivir)的需求却异常旺盛。当疫情爆发最严重时,抗病毒药物用于治疗患者。因此,仿制药注射剂市场的制造商现在已为未来做好了准备,因为他们专注于保持充足的库存,以保持供应链运营不因任何类型的漏洞而受到影响。例如,吉利德科学公司和其他大型制药公司已大幅降低瑞德西韦仿制药的价格。公司正在利用 BFSI 行业提供的政府计划和融资计划来简化其运营。 2020 年 5 月,美国政府与一批美国仿制药制造商签署了一项价值 8.12 亿美元的协议,目标是在全球 COVID-19 大流行期间加强美国的药品供应。

此外,疫情给全球制药业带来压力,导致各种关键药品的供应中断和延迟。不少市场主体立即出手救市。例如,2021年1月,Civica Rx与全新的Phlow Corp.合作,努力支持美国的药品生产,并向抗击大流行的医院提供关键药物。 Civica 投资 1.245 亿美元在弗吉尼亚州彼得堡建设无菌注射剂生产设施,该设施去年因一份生产 COVID-19 相关药物的大型政府合同而声名鹊起。

基于从地区来看,仿制药注射剂市场分为北美、欧洲、亚太地区、中东和非洲。非洲、南美和非洲中美洲。

仿制药注射剂市场利润丰厚的地区

市场洞察
价格实惠的药物推动仿制药注射剂市场

由于在研究和开发方面的高投资,创新药物价格昂贵。分子的发育;对于发展中国家的很大一部分人口来说,这些药物尤其是买不起的。然而,仿制药价格实惠,并且可以提供更多的医疗服务。根据无障碍药物协会 (AAM) 公布的数据,仿制药的平均主要自付额(由保险计划设定的金额)为 6.06 美元,品牌药为 40.30 美元。这一事实表明仿制药价格至少下降了约 7%。根据美国退休人员协会 (AARP) 的数据,品牌药品价格继续以比通货膨胀快 100 倍的速度上涨。而且,正如美国FDA提到的,在美国开出的9/10处方都是仿制药。此外,仿制药的平均制造商价格 (AMP) 比品牌药的 AMP 低约 39%。例如,根据无障碍药物协会 (AAM) 的公布,93% 的仿制药处方价格为 20 美元或以下。上述事实促进了仿制药注射剂的需求和供应,从而推动更多参与者进入仿制药注射剂市场。

此外,仿制药注射剂的低廉价格有助于更好、更有效地治疗慢性病。根据世界卫生组织 (WHO) 的数据,到 2021 年,全球约有 4.22 亿人患有糖尿病。胰岛素注射等通用注射剂可以立即解决此类疾病,同时确保发展中国家获得负担得起的治疗。

基于产品类型的洞察

根据产品类型,仿制药注射剂市场分为大分子注射剂和小分子注射剂。 2021年,大分子注射剂细分市场占据更大的市场份额。该细分市场的市场地位归功于医疗保健领域生物制剂的采用激增,以及单克隆抗体和抗体药物偶联物 (ADC) 在药物开发中的进展。

仿制药注射剂市场(按产品类型) 2020年和2028年

基于容器类型的见解

根据容器类型,通用注射剂市场分为西林瓶、预混剂、预充注射器、安瓿、和别的。西林瓶细分市场可能会在 2021 年占据市场主导地位。

基于应用的见解

基于应用的通用注射剂市场已经分为肿瘤学、传染病学、心脏病学、糖尿病学、免疫学等。肿瘤学领域可能会在 2021 年占据最大的市场份额。癌症发病率的增加和药物上市的增加预计将推动肿瘤学市场领域的增长。

 

基于给药途径的见解

根据给药途径,仿制药注射剂市场可分为静脉注射、肌肉注射、皮下注射等。 2021 年,静脉注射细分市场占据最大的市场份额。

仿制药注射剂市场参与者采取产品推出和扩张等有机策略来扩大其在全球的足迹和产品组合。

按地理位置

  • 北美
    • 美国
    • 加拿大
    • < li>墨西哥
  • 欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 中国
    • < li>印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和中东地区非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
ul>

公司简介

  • 阿斯利康
  • 百特国际公司
  • Biocon
  • 费森尤斯 SE & Co. KGaA
  • 葛兰素史克公司
  • Hikma Pharmaceuticals
  • 强生公司约翰逊服务公司
  • 卢平有限公司
  • 默克公司有限公司
  • Mylan NV
  • 辉瑞公司            ;                                  &n公共服务提供商;                 
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the generic injectables market?

Generic Injectables are safe and effective innovator bio-equivalent drugs of their branded counterparts which are not protected by drug patents. They have a similar ingredient, dosage, strength, quality, form, etc.

What are the driving factors for the generic injectables market across the globe?

High demand for affordable drugs is one of the most significant factors responsible for the overall market growth.

Which segment led the generic injectables market?

Based on product type, large molecule injectables took the forefront leaders in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

Which application segment held the largest revenue (US$ Mn) in the medical laser system market?

The oncology segment dominated the global generic injectables market and accounted for the largest revenue of 21.62 Bn in 2021.

Who are the key players in the generic injectables market?

Astrazeneca, Baxter International, Inc., Biocon, Fresenius SE & Co., KGaA, GlaxoSmithKline Plc, Hikma Pharmaceuticals, Johnson & Johnson Services, Inc., Lupin, Ltd., Merck & Co., Inc., Mylan N.V., Pfizer, Inc. are among the leading companies operating in the global generic injectables market

What is the regional market scenario of the generic injectables market?

Global generic injectables market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for generic injectables market. The US is estimated to hold the largest share in the generic injectables market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia-Pacific regional growth for generic injectables accounting fastest growth of the region during the coming years.

The List of Companies - Generic Injectables Market

  1. Astrazeneca
  2. Baxter International, Inc.
  3. Biocon
  4. Fresenius SE & Co. KGaA
  5. GlaxoSmithKline Plc
  6. Hikma Pharmaceuticals
  7. Johnson & Johnson Services, Inc.
  8. Lupin, Ltd.
  9. Merck & Co., Inc.
  10. Mylan N.V.
  11. Pfizer, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports